Tenet Healthcare (NYSE:THC) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Posted by Stanley Muller on Jul 28th, 2026

Tenet Healthcare (NYSE:THC – Get Free Report) had its price target hoisted by analysts at Robert W. Baird from $210.00 to $280.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Robert W. Baird’s target price indicates a potential upside of 15.50% from the company’s previous close.

A number of other brokerages also recently weighed in on THC. Wall Street Zen upgraded Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Sunday. KeyCorp lowered their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Piper Sandler set a $308.00 price objective on Tenet Healthcare in a report on Monday. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research report on Monday. Finally, Morgan Stanley raised their price target on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $263.45.

View Our Latest Analysis on Tenet Healthcare

Tenet Healthcare Trading Up 4.0%

Shares of NYSE:THC opened at $242.42 on Tuesday. The stock has a market capitalization of $20.88 billion, a price-to-earnings ratio of 9.35, a PEG ratio of 1.61 and a beta of 1.27. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company has a 50 day moving average price of $186.16 and a 200 day moving average price of $197.79. Tenet Healthcare has a 1-year low of $151.00 and a 1-year high of $248.82.

Tenet Healthcare (NYSE:THC – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.Tenet Healthcare’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.02 earnings per share. On average, research analysts anticipate that Tenet Healthcare will post 21 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.97% of the stock is currently owned by corporate insiders.

Institutional Trading of Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Triumph Capital Management bought a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare during the fourth quarter worth $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare during the fourth quarter valued at $29,000. Meeder Asset Management Inc. grew its holdings in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare in the second quarter valued at about $35,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.